Ghanaian Health Service officials have said that Zinc together with Zithromax is being used to treat persons infected with COVID-19.
Zithromax, an antibiotic fights bacteria and is said to be effective with Covid-19, when used with Zinc.
It can also be used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases.
According to the country’s Director-General of the Ghana Health Service the drugs are effective in managing persons with the virus.
Dr. Kuma-Aboagye told journalists in Accra on Tuesday that officials also intend using hydroxychloroquine once it is approved as well.
He said “Very soon, our results will come out for us to know whether the people on Zithromax and those who are on Hydroxy Chloroquine alone will be the outcome. I think that will be very helpful.”
Kuma-Aboagye added that “What we also know is that Zinc helps to protect the mucosal line. If it is weak, it is easier for a virus to enter. So it has some protection of the lining of the mouth, the nose that does not have easy access to the virus.
That is why we do that and add vitamin C. Zithromax also provides secondary protection because it is antibacterial, so if you have some antibacterial infection, it offers some protection. But the hydro chloroquine, when the results come, we will see whether it works for us for a decision to be taken.”
In some countries, doctors are reported to be adding Zinc to hydrochloroquine to treat patients with the virus.
This week a Nigerian-born doctor, Stella Immanuel made the headlines after her passionate plea for health practitioners across the world to use hydroxychloroquine for the treatment of Covid 19.
In a video that has one viral on social media, she argues in support of the controversial treatment despite warnings from other experts including the FDA in America.
Stella Immanuel is part of a team of Medical professionals that attended the America’s Frontline Doctors Summit in front of the U.S. Supreme Court in Washington, D.C. on Monday, July 27.
According to the FDA in America, hydroxychloroquine or chloroquine as a treatment for COVID-19 patients had no benefits.
Other countries also halted their clinical trials into the drug stating same positions on benefits.
In May this year many African countries defied a warning from the World Health Organization on the safety of the anti-Malarial drug called hydroxychloroquine for treatment of Covid-19 patients.
The WHO had said at the time that it was halting clinical trials on the anti-malaria drug because of safety fears.
But in Africa many countries ignored this caution and declaring their intentions to proceed with clinical trials and using the drug to treat patients.
The director of Nigeria’s National Agency for Food and Drug Administration and Control (Nafdac), Mojisola Adeyeye said in a media interview that she does not dispute WHO’s conclusions but they want to generate their own data.
She was quoted as saying that “I do not know the data that they’re looking at, whether it’s from the Caucasian population or from the African population.
If the data they’re looking at and the reason for suspending the trials is from Caucasian population, then it may be justified. But I don’t think we have data from the African population yet, because our genetic make up is different.”